9565011000001102: Tarceva 150mg tablets (Roche Products Ltd) (product)

• SNOMED CT Concept\Pharmaceutical / biologic product\...
• \UK product\Actual medicinal product\Tarceva 150mg tablets (Roche Products Ltd)
• \UK product\Virtual medicinal product\Product containing precisely erlotinib (as erlotinib hydrochloride) 150 milligram/1 each conventional release oral tablet\Tarceva 150mg tablets (Roche Products Ltd)
• \UK product\Virtual therapeutic moiety\Erlotinib\Product containing only erlotinib in oral dose form (medicinal product form)\Product containing precisely erlotinib (as erlotinib hydrochloride) 150 milligram/1 each conventional release oral tablet\Tarceva 150mg tablets (Roche Products Ltd)
• \UK product\Virtual therapeutic moiety\Erlotinib\Product containing precisely erlotinib (as erlotinib hydrochloride) 150 milligram/1 each conventional release oral tablet\Tarceva 150mg tablets (Roche Products Ltd)
• \UK product\Trade family\Tarceva\Tarceva 150mg tablets (Roche Products Ltd)
• \Medicinal product\Medicinal product categorized by disposition\Product containing enzyme inhibitor\Product containing transferase inhibitor\Product containing phosphotransferase inhibitor\Product containing protein kinase inhibitor\Medicinal product containing epidermal growth factor receptor antagonist and acting as antineoplastic agent (product)\Product containing erlotinib\Erlotinib\Product containing only erlotinib in oral dose form (medicinal product form)\Product containing precisely erlotinib (as erlotinib hydrochloride) 150 milligram/1 each conventional release oral tablet\Tarceva 150mg tablets (Roche Products Ltd)
• \Medicinal product\Medicinal product categorized by disposition\Product containing enzyme inhibitor\Product containing transferase inhibitor\Product containing phosphotransferase inhibitor\Product containing protein kinase inhibitor\Medicinal product containing epidermal growth factor receptor antagonist and acting as antineoplastic agent (product)\Product containing erlotinib\Erlotinib\Product containing precisely erlotinib (as erlotinib hydrochloride) 150 milligram/1 each conventional release oral tablet\Tarceva 150mg tablets (Roche Products Ltd)
• \Medicinal product\Medicinal product categorized by disposition\Product containing enzyme inhibitor\Product containing transferase inhibitor\Product containing phosphotransferase inhibitor\Product containing protein kinase inhibitor\Medicinal product containing epidermal growth factor receptor antagonist and acting as antineoplastic agent (product)\Product containing erlotinib\Product containing erlotinib in oral dose form (medicinal product form)\Product containing only erlotinib in oral dose form (medicinal product form)\Product containing precisely erlotinib (as erlotinib hydrochloride) 150 milligram/1 each conventional release oral tablet\Tarceva 150mg tablets (Roche Products Ltd)
• \Medicinal product\Medicinal product categorized by disposition\Product containing enzyme inhibitor\Product containing transferase inhibitor\Product containing phosphotransferase inhibitor\Product containing protein kinase inhibitor\Product containing protein-tyrosine kinase inhibitor\Product containing erlotinib\Erlotinib\Product containing only erlotinib in oral dose form (medicinal product form)\Product containing precisely erlotinib (as erlotinib hydrochloride) 150 milligram/1 each conventional release oral tablet\Tarceva 150mg tablets (Roche Products Ltd)
• \Medicinal product\Medicinal product categorized by disposition\Product containing enzyme inhibitor\Product containing transferase inhibitor\Product containing phosphotransferase inhibitor\Product containing protein kinase inhibitor\Product containing protein-tyrosine kinase inhibitor\Product containing erlotinib\Erlotinib\Product containing precisely erlotinib (as erlotinib hydrochloride) 150 milligram/1 each conventional release oral tablet\Tarceva 150mg tablets (Roche Products Ltd)
• \Medicinal product\Medicinal product categorized by disposition\Product containing enzyme inhibitor\Product containing transferase inhibitor\Product containing phosphotransferase inhibitor\Product containing protein kinase inhibitor\Product containing protein-tyrosine kinase inhibitor\Product containing erlotinib\Product containing erlotinib in oral dose form (medicinal product form)\Product containing only erlotinib in oral dose form (medicinal product form)\Product containing precisely erlotinib (as erlotinib hydrochloride) 150 milligram/1 each conventional release oral tablet\Tarceva 150mg tablets (Roche Products Ltd)
• \Medicinal product\Medicinal product categorized by structure\Product containing substance with ether structure (product)\Product containing erlotinib\Erlotinib\Product containing only erlotinib in oral dose form (medicinal product form)\Product containing precisely erlotinib (as erlotinib hydrochloride) 150 milligram/1 each conventional release oral tablet\Tarceva 150mg tablets (Roche Products Ltd)
• \Medicinal product\Medicinal product categorized by structure\Product containing substance with ether structure (product)\Product containing erlotinib\Erlotinib\Product containing precisely erlotinib (as erlotinib hydrochloride) 150 milligram/1 each conventional release oral tablet\Tarceva 150mg tablets (Roche Products Ltd)
• \Medicinal product\Medicinal product categorized by structure\Product containing substance with ether structure (product)\Product containing erlotinib\Product containing erlotinib in oral dose form (medicinal product form)\Product containing only erlotinib in oral dose form (medicinal product form)\Product containing precisely erlotinib (as erlotinib hydrochloride) 150 milligram/1 each conventional release oral tablet\Tarceva 150mg tablets (Roche Products Ltd)
• \Medicinal product\Medicinal product categorized by structure\Product containing quinazoline\Product containing erlotinib\Erlotinib\Product containing only erlotinib in oral dose form (medicinal product form)\Product containing precisely erlotinib (as erlotinib hydrochloride) 150 milligram/1 each conventional release oral tablet\Tarceva 150mg tablets (Roche Products Ltd)
• \Medicinal product\Medicinal product categorized by structure\Product containing quinazoline\Product containing erlotinib\Erlotinib\Product containing precisely erlotinib (as erlotinib hydrochloride) 150 milligram/1 each conventional release oral tablet\Tarceva 150mg tablets (Roche Products Ltd)
• \Medicinal product\Medicinal product categorized by structure\Product containing quinazoline\Product containing erlotinib\Product containing erlotinib in oral dose form (medicinal product form)\Product containing only erlotinib in oral dose form (medicinal product form)\Product containing precisely erlotinib (as erlotinib hydrochloride) 150 milligram/1 each conventional release oral tablet\Tarceva 150mg tablets (Roche Products Ltd)
• \Medicinal product\Medicinal product categorized by therapeutic role\Medicinal product acting as antineoplastic agent (product)\Medicinal product containing epidermal growth factor receptor antagonist and acting as antineoplastic agent (product)\Product containing erlotinib\Erlotinib\Product containing only erlotinib in oral dose form (medicinal product form)\Product containing precisely erlotinib (as erlotinib hydrochloride) 150 milligram/1 each conventional release oral tablet\Tarceva 150mg tablets (Roche Products Ltd)
• \Medicinal product\Medicinal product categorized by therapeutic role\Medicinal product acting as antineoplastic agent (product)\Medicinal product containing epidermal growth factor receptor antagonist and acting as antineoplastic agent (product)\Product containing erlotinib\Erlotinib\Product containing precisely erlotinib (as erlotinib hydrochloride) 150 milligram/1 each conventional release oral tablet\Tarceva 150mg tablets (Roche Products Ltd)
• \Medicinal product\Medicinal product categorized by therapeutic role\Medicinal product acting as antineoplastic agent (product)\Medicinal product containing epidermal growth factor receptor antagonist and acting as antineoplastic agent (product)\Product containing erlotinib\Product containing erlotinib in oral dose form (medicinal product form)\Product containing only erlotinib in oral dose form (medicinal product form)\Product containing precisely erlotinib (as erlotinib hydrochloride) 150 milligram/1 each conventional release oral tablet\Tarceva 150mg tablets (Roche Products Ltd)
• \Medicinal product\Product manufactured as oral dose form\Product containing erlotinib in oral dose form (medicinal product form)\Product containing only erlotinib in oral dose form (medicinal product form)\Product containing precisely erlotinib (as erlotinib hydrochloride) 150 milligram/1 each conventional release oral tablet\Tarceva 150mg tablets (Roche Products Ltd)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 01-May 2006. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id	Description	Lang	Type	Status	Case?	Module
31139301000001114	Tarceva 150mg tablets (Roche Products Ltd) (product)	en	Fully specified name	Active	Only initial character case insensitive	SNOMED CT United Kingdom drug extension module
31139401000001118	Tarceva 150mg tablets (Roche Products Ltd)	en	Synonym	Active	Only initial character case insensitive	SNOMED CT United Kingdom drug extension module

Expanded Value Set

This concept is not in any reference sets

Back to Start